Log In
Wednesday 21st February 2018

NICE ban heart drug

27th January 2010

The National Institute for Health and Clinical Excellence has decided that a type of heart medication used to treat abnormal heartbeats is not 'cost effective'.

Cardiologists have composed an open letter to NICE in protest, saying that the drug, dronedarone, could help 40,000 people with the condition. They wrote: "The draft guidance is a shocking decision, based on cost saving and will be extremely detrimental to many patients with AF, their carers and their medical professionals - all of whom had looked to this innovative treatment as a chance to restore long-term health and improve quality of life for appropriate-patients."

Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2018